Selected research
Market Structure
Global Bifunctional Epoxide Hydrolase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bifunctional Epoxide Hydrolase 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bifunctional Epoxide Hydrolase 2 include Sumitomo Dainippon Pharma Co., Ltd., GlaxoSmithKline Plc, Toray Industries, Inc. and Sphaera Pharma Pvt. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bifunctional Epoxide Hydrolase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bifunctional Epoxide Hydrolase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bifunctional Epoxide Hydrolase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifunctional Epoxide Hydrolase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.
Bifunctional Epoxide Hydrolase 2 Segment by Company
Sumitomo Dainippon Pharma Co., Ltd.
GlaxoSmithKline Plc
Toray Industries, Inc.
Sphaera Pharma Pvt. Ltd.
Bifunctional Epoxide Hydrolase 2 Segment by Type
EC-5026
GSK-2256294
RB-394
Others
Bifunctional Epoxide Hydrolase 2 Segment by Application
Kidney Cancer
Liver Cancer
Lung Cancer
Others
Bifunctional Epoxide Hydrolase 2 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifunctional Epoxide Hydrolase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifunctional Epoxide Hydrolase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifunctional Epoxide Hydrolase 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bifunctional Epoxide Hydrolase 2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bifunctional Epoxide Hydrolase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bifunctional Epoxide Hydrolase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bifunctional Epoxide Hydrolase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EC-5026
- GSK-2256294
- RB-394
- Others
Applications
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Sumitomo Dainippon Pharma Co., Ltd.
- GlaxoSmithKline Plc
- Toray Industries, Inc.
- Sphaera Pharma Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bifunctional Epoxide Hydrolase 2 Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bifunctional Epoxide Hydrolase 2 Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bifunctional Epoxide Hydrolase 2 Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bifunctional Epoxide Hydrolase 2 Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bifunctional Epoxide Hydrolase 2 Market Dynamics
- 2.1 Bifunctional Epoxide Hydrolase 2 Industry Trends
- 2.2 Bifunctional Epoxide Hydrolase 2 Industry Drivers
- 2.3 Bifunctional Epoxide Hydrolase 2 Industry Opportunities and Challenges
- 2.4 Bifunctional Epoxide Hydrolase 2 Industry Restraints
3 Bifunctional Epoxide Hydrolase 2 Market by Manufacturers
- 3.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Manufacturers (2021-2026)
- 3.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Manufacturers (2021-2026)
- 3.3 Global Bifunctional Epoxide Hydrolase 2 Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bifunctional Epoxide Hydrolase 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifunctional Epoxide Hydrolase 2 Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bifunctional Epoxide Hydrolase 2 Manufacturers, Product Type & Application
- 3.7 Global Bifunctional Epoxide Hydrolase 2 Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bifunctional Epoxide Hydrolase 2 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bifunctional Epoxide Hydrolase 2 Players Market Share by Revenue in 2025
- 3.8.3 2025 Bifunctional Epoxide Hydrolase 2 Tier 1, Tier 2, and Tier 3
4 Bifunctional Epoxide Hydrolase 2 Market by Type
- 4.1 Bifunctional Epoxide Hydrolase 2 Type Introduction
- 4.1.1 EC-5026
- 4.1.2 GSK-2256294
- 4.1.3 RB-394
- 4.1.4 Others
- 4.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Type
- 4.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Type (2021-2032)
- 4.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Type (2021-2032)
- 4.3 Global Bifunctional Epoxide Hydrolase 2 Revenue by Type
- 4.3.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Type (2021-2032)
- 4.3.3 Global Bifunctional Epoxide Hydrolase 2 Revenue Market Share by Type (2021-2032)
5 Bifunctional Epoxide Hydrolase 2 Market by Application
- 5.1 Bifunctional Epoxide Hydrolase 2 Application Introduction
- 5.1.1 Kidney Cancer
- 5.1.2 Liver Cancer
- 5.1.3 Lung Cancer
- 5.1.4 Others
- 5.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Application
- 5.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Application (2021-2032)
- 5.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Application (2021-2032)
- 5.3 Global Bifunctional Epoxide Hydrolase 2 Revenue by Application
- 5.3.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Application (2021-2032)
- 5.3.3 Global Bifunctional Epoxide Hydrolase 2 Revenue Market Share by Application (2021-2032)
6 Global Bifunctional Epoxide Hydrolase 2 Sales by Region
- 6.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2021-2032)
- 6.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2021-2026)
- 6.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bifunctional Epoxide Hydrolase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bifunctional Epoxide Hydrolase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bifunctional Epoxide Hydrolase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bifunctional Epoxide Hydrolase 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region
- 7.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region
- 7.1.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region (2021-2026)
- 7.1.3 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region (2027-2032)
- 7.1.4 Global Bifunctional Epoxide Hydrolase 2 Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bifunctional Epoxide Hydrolase 2 Revenue (2021-2032)
- 7.2.2 North America Bifunctional Epoxide Hydrolase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bifunctional Epoxide Hydrolase 2 Revenue (2021-2032)
- 7.3.2 Europe Bifunctional Epoxide Hydrolase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bifunctional Epoxide Hydrolase 2 Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bifunctional Epoxide Hydrolase 2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sumitomo Dainippon Pharma Co., Ltd.
- 8.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 8.1.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 8.1.3 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 8.2 GlaxoSmithKline Plc
- 8.2.1 GlaxoSmithKline Plc Company Information
- 8.2.2 GlaxoSmithKline Plc Business Overview
- 8.2.3 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.2.5 GlaxoSmithKline Plc Recent Developments
- 8.3 Toray Industries, Inc.
- 8.3.1 Toray Industries, Inc. Company Information
- 8.3.2 Toray Industries, Inc. Business Overview
- 8.3.3 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.3.5 Toray Industries, Inc. Recent Developments
- 8.4 Sphaera Pharma Pvt. Ltd.
- 8.4.1 Sphaera Pharma Pvt. Ltd. Company Information
- 8.4.2 Sphaera Pharma Pvt. Ltd. Business Overview
- 8.4.3 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.4.5 Sphaera Pharma Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bifunctional Epoxide Hydrolase 2 Value Chain Analysis
- 9.1.1 Bifunctional Epoxide Hydrolase 2 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bifunctional Epoxide Hydrolase 2 Production Mode & Process
- 9.2 Bifunctional Epoxide Hydrolase 2 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifunctional Epoxide Hydrolase 2 Distributors
- 9.2.3 Bifunctional Epoxide Hydrolase 2 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst